Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Why the iShares Semiconductor ETF (SOXX) Jumped 40% in 2025: https://g.foolcdn.com/editorial/images/851537/etf-with-digital-design.jpg
Why the iShares Semiconductor ETF (SOXX) Jumped 40% in 2025

Shares of the iShares Semiconductor ETF (NASDAQ: SOXX) were soaring last year, reflecting the continuing AI boom, and gains in top members like Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ:

Why Global X Artificial Intelligence and Technology ETF (AIQ) Jumped 31% in 2025: https://g.foolcdn.com/editorial/images/851658/ai-letters.jpg
Why Global X Artificial Intelligence and Technology ETF (AIQ) Jumped 31% in 2025

Artificial intelligence (AI) stocks soared last year, and exchange-traded funds (ETFs) that focus on AI stocks jumped as well.

One of those ETFs was the Global X Artificial Intelligence and

Why This Stock's Recent Weakness Could Be a Gift for Patient Investors: https://g.foolcdn.com/editorial/images/849981/gettyimages-1461323126-1200x675-128554e.jpg
Why This Stock's Recent Weakness Could Be a Gift for Patient Investors

It's easy to hold a growth stock and feel good about it when that asset is outperforming the S&P 500. However, corrections can test an investor's patience and cause people to exit great companies

Stock Market Today, Jan. 16: ImmunityBio Soars After Anktiva Revenue Jumps 700 Percent Year Over Year
Stock Market Today, Jan. 16: ImmunityBio Soars After Anktiva Revenue Jumps 700 Percent Year Over Year

ImmunityBio (NASDAQ:IBRX), cancer and infectious disease immunotherapy developer, closed Friday at $5.52, up 39.75% for the session. The stock climbed after Premarket updates highlighted explosive

Why ImmunityBio Stock Is Skyrocketing Again Today: https://g.foolcdn.com/editorial/images/851657/gettyimages-1205459956.jpg
Why ImmunityBio Stock Is Skyrocketing Again Today

Shares of cancer and infectious disease therapy developer ImmunityBio, Inc. (NASDAQ: IBRX), spiked 34% higher as of 1 p.m. ET on Friday and are now up a staggering 127% this week after an incredible

Why Shares of Riot Platforms Are Surging Today: https://g.foolcdn.com/editorial/images/851661/positive-person-3.jpg
Why Shares of Riot Platforms Are Surging Today

Shares of the Bitcoin miner Riot Platforms (NASDAQ: RIOT) traded nearly 13.5% higher today, as of 1:11 p.m. ET. The company announced the acquisition of land and a lease agreement with chipmaker

Why InterDigital Could Be a Huge AI Winner That Investors Ignore at Their Peril: https://g.foolcdn.com/editorial/images/851649/mobile-data-getty.jpg
Why InterDigital Could Be a Huge AI Winner That Investors Ignore at Their Peril

The amazing returns that technology stocks have generated for more than a decade now have attracted countless investors to the sector. Many of the best-known tech stocks profit from creating

3 Dividend Champions to Buy and Hold for Decades: https://g.foolcdn.com/editorial/images/850688/nike.jpeg
3 Dividend Champions to Buy and Hold for Decades

There's a saying on Wall Street that "dividends don't lie." Just about every financial metric can be spun by a company's management, but dividends either arrive in the mail or they don't. Companies

Nvidia H200 and AMD MI325X Got Hit With New Tariffs: https://g.foolcdn.com/editorial/images/851456/charts-32.png
Nvidia H200 and AMD MI325X Got Hit With New Tariffs

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,

Stock Market Today, Jan. 15: Nvidia Rises on Strong AI Demand and Data Center Growth Optimism
Stock Market Today, Jan. 15: Nvidia Rises on Strong AI Demand and Data Center Growth Optimism

Nvidia (NASDAQ:NVDA), the leading developer of GPUs and AI solutions for data centers, closed Thursday at $187.05, up 2.13%. Shares moved higher as investors responded to renewed evidence of robust

Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%: https://cdn.content.foolcdn.com/images/1umn9qeh/production/23fc1b822f8eafa9d627ca7fbac8d5b39aebf467-1401x1251.png?w=1401&h=1251
Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%

ImmunityBio (NASDAQ:IBRX), a cancer and infectious-disease drug developer, closed Thursday at $3.95, up 30.79% for the session. The stock jumped after preliminary 2025 results highlighted roughly

3 Absurdly Cheap Growth Stocks to Buy in 2026: https://g.foolcdn.com/editorial/images/850646/person-looking-at-stock-charts-with-a-child.jpg
3 Absurdly Cheap Growth Stocks to Buy in 2026

If you want to set yourself up for good long-term returns, it's important to consider a stock's valuation. Even if you invest in great companies, if you're paying a massive premium for them, your

Is AMD Stock a Buy After Its CES Keynote?: https://g.foolcdn.com/editorial/images/851453/new-cc-32.png
Is AMD Stock a Buy After Its CES Keynote?

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

Why AMD and Intel Shareholders Could Have a Strong Year: https://g.foolcdn.com/editorial/images/851454/charts-30.png
Why AMD and Intel Shareholders Could Have a Strong Year

In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,

2 Artificial Intelligence (AI) Stocks Poised to Run in 2026 and Beyond: https://g.foolcdn.com/editorial/images/850740/blocks-with-arrows-pointing-up-building-growth.png
2 Artificial Intelligence (AI) Stocks Poised to Run in 2026 and Beyond

Top technology companies that are meeting the demand for chips and other artificial intelligence compute requirements have delivered excellent returns to investors over the past few years.

Leading

Why Voyager Technologies Stock Surged Today: https://g.foolcdn.com/editorial/images/851355/iss-international-space-station-orbiting-over-a-hurricane.jpg
Why Voyager Technologies Stock Surged Today

Leading the team of companies planning to build a privately owned Starlab space station to replace the International Space Station in 2030, Voyager Technologies (NYSE: VOYG) arguably has the best

Stock Market Today, Jan. 13: Nvidia Rises on H200 Export Developments
Stock Market Today, Jan. 13: Nvidia Rises on H200 Export Developments

AI giant, Nvidia (NASDAQ:NVDA), closed Tuesday’s session at $185.81, up 0.47%. Trading volume reached 158.40 million shares, coming in 16.51% below its three-month average of 184.56 million shares.

Stock Market Today, Jan. 13: AMD Rallies as Banking Stocks Struggle: https://cdn.content.foolcdn.com/images/1umn9qeh/production/77da40e1441423dea3c02d00c83ecbebd96a733e-1401x1250.png?w=1401&h=1250
Stock Market Today, Jan. 13: AMD Rallies as Banking Stocks Struggle

The S&P 500 (SNPINDEX:^GSPC) slipped 0.19% to 6,963.74 today even as December CPI data came in slightly lower than expected. The Nasdaq Composite (NASDAQINDEX:^IXIC) eased 0.10% to 23,709.87, and

1 Quantum Computing Stock to Buy that Could Soar in 2026: https://g.foolcdn.com/editorial/images/850184/gettyimages-1347310377.jpg
1 Quantum Computing Stock to Buy that Could Soar in 2026

Quantum computing is moving from the theoretical to the commercially applicable, but only one company has achieved 99.99% two-qubit gate fidelity (a measure of results accuracy). That company is

This Top Gold Stock Could Keep Climbing in 2026: https://g.foolcdn.com/editorial/images/850876/gold-conveyer-getty.jpg
This Top Gold Stock Could Keep Climbing in 2026

As economic uncertainty has grown, investors have increasingly turned to gold as an alternative to traditional investments in stocks, bonds, and other asset classes. Gold soared in 2025, and already

Buy These 3 AI ETFs Now: They Could Be Worth $15 Million in 30 Years: https://g.foolcdn.com/editorial/images/847713/gettyimages-2078917109.jpg
Buy These 3 AI ETFs Now: They Could Be Worth $15 Million in 30 Years

There is no hotter segment of the market right now than artificial intelligence (AI). AI stocks have powered the market higher over the past few years, and the technology still looks like it is in

Prediction: This Artificial Intelligence (AI) Chip Stock Will Outperform Nvidia in 2026 (Hint: It's Not AMD): https://g.foolcdn.com/editorial/images/850416/micron-building-at-night-with-micron-logo-on-top_micron-1.jpg
Prediction: This Artificial Intelligence (AI) Chip Stock Will Outperform Nvidia in 2026 (Hint: It's Not AMD)

The rise of artificial intelligence (AI) has ushered in a generational growth wave for companies all across the technology arena. In particular, semiconductor stocks have been some of the greatest

Agnico Eagle Has Been a Gold Mine for Shareholders -- And It's Just Getting Started: https://g.foolcdn.com/editorial/images/850755/gold-getty.jpg
Agnico Eagle Has Been a Gold Mine for Shareholders -- And It's Just Getting Started

2025 was a great year for gold stocks, as prices of precious metals soared. Demand came from several quarters, including both the perception of gold as a store of value during troubled times and a

Celldex Therapeutics SVPs Engage In Heavy Transactions
Celldex Therapeutics SVPs Engage In Heavy Transactions

On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President & General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.

VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)